Published in Pharma Investments, Ventures and Law Weekly, June 4th, 2006
Net sales for the third quarter were $80.8 million, compared to $82.5 million in the third quarter of fiscal year 2005. The company's selling, general and administrative expenses decreased 18% from the third quarter of last year, producing a 43% increase in operating income to $4.1 million. Aceto reported net income of $2.8 million or $0.11 per diluted share, a 45% increase from $1.9 million or $0.08 per diluted share in the 2005...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Pharma Investments, Ventures and Law Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.